Lista de obras - Luisella Righi - Dominio Público Uruguay

A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer

artículo científico publicado en 2005

An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation

artículo científico publicado en 2015

BRCA1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: A Large Retrospective Study.

artículo científico publicado en 2016

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.

artículo científico publicado en 2017

Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression.

artículo científico publicado en 2017

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome

artículo científico publicado en 2014

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.

artículo científico publicado en 2016

Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases.

artículo científico publicado en 2009

Classification of pulmonary neuroendocrine tumors: new insights

artículo científico publicado en 2017

Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.

artículo científico publicado en 2014

Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing.

artículo científico publicado en 2013

Diffusion-weighted quantitative MRI of pleural abnormalities: Intra- and interobserver variability in the apparent diffusion coefficient measurements

artículo científico publicado en 2017

Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge

artículo científico publicado en 2015

Does Immunohistochemistry Represent a Robust Alternative Technique in Determining Drugable Predictive Gene Alterations in Non-Small Cell Lung Cancer?

artículo científico

EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer

artículo científico publicado en 2015

Emerging role of thymidylate synthase for the pharmacogenomic selection of patients with thoracic cancer

artículo científico publicado en 2010

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)-from morphology to molecular testing.

artículo científico publicado en 2017

Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer.

artículo científico publicado en 2009

Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates

artículo científico publicado en 2003

Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas.

artículo científico publicado en 2015

Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer.

artículo científico publicado en 2011

Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma

artículo científico publicado en 2017

Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

artículo científico publicado en 2013

Helical-Tip Needle for Transthoracic Percutaneous Image-Guided Biopsy of Lung Tumors: Results of a Pilot Prospective Comparative Study with a Standard Tru-Cut Needle.

artículo científico publicado en 2017

Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma

artículo científico

Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors.

artículo científico publicado en 2018

Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression.

artículo científico publicado en 2015

Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation

artículo científico publicado en 2011

Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome

artículo científico publicado en 2014

Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area

artículo científico publicado en 2014

Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.

artículo científico publicado en 2014

Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied

artículo científico publicado en 2017

Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma

scientific article published on 26 March 2018

Lung neuroendocrine tumors: pathological characteristics

artículo científico publicado en 2017

Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.

artículo científico publicado en 2010

Mesothelioma families without inheritance of a BAP1 predisposing mutation.

artículo científico publicado en 2016

Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study.

artículo científico publicado en 2015

Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma.

artículo científico publicado en 2017

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.

artículo científico publicado en 2015

Multicenter comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) assays to test PD-L1 expression for NSCLC patients to be treated with immune checkpoint inhibitors

artículo científico publicado en 2017

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images

artículo científico publicado en 2021

Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.

artículo científico publicado en 2014

Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data.

artículo científico publicado en 2007

Neuroendocrine differentiation in breast cancer: established facts and unresolved problems

scientific article published on 01 February 2010

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal

artículo científico publicado en 2018

Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research.

artículo científico publicado en 2016

Prognostic role of osteopontin expression in malignant pleural mesothelioma

scientific article published on 01 July 2008

Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.

artículo científico publicado en 2016

Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells.

artículo científico publicado en 2003

Role of surgical resection in colorectal lung metastases: analysis of 137 patients

artículo científico publicado en 2010

Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy era.

artículo científico publicado en 2015

Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes

article

Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.

artículo científico publicado en 2018

Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases.

artículo científico publicado en 2009

Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy

scientific article published on 14 September 2007

Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum

artículo científico publicado en 2002

Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.

artículo científico publicado en 2015

The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers

artículo científico publicado en 2011

Therapeutic biomarkers in lung neuroendocrine neoplasia.

artículo científico

Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy.

artículo científico publicado en 2010

Tumor/stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis.

artículo científico publicado en 2014

What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?

artículo científico publicado en 2015

ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization

artículo científico publicado en 2013

Lista de obras de Luisella Righi

A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer

An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation

BRCA1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: A Large Retrospective Study.

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.

Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression.

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.

Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases.

Classification of pulmonary neuroendocrine tumors: new insights

Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.

Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing.

Diffusion-weighted quantitative MRI of pleural abnormalities: Intra- and interobserver variability in the apparent diffusion coefficient measurements

Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge

Does Immunohistochemistry Represent a Robust Alternative Technique in Determining Drugable Predictive Gene Alterations in Non-Small Cell Lung Cancer?

EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer

Emerging role of thymidylate synthase for the pharmacogenomic selection of patients with thoracic cancer

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)-from morphology to molecular testing.

Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer.

Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates

Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas.

Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer.

Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma

Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

Helical-Tip Needle for Transthoracic Percutaneous Image-Guided Biopsy of Lung Tumors: Results of a Pilot Prospective Comparative Study with a Standard Tru-Cut Needle.

Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma

Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors.

Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression.

Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation

Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome

Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area

Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.

Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied

Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma

Lung neuroendocrine tumors: pathological characteristics

Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.

Mesothelioma families without inheritance of a BAP1 predisposing mutation.

Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study.

Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma.

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.

Multicenter comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) assays to test PD-L1 expression for NSCLC patients to be treated with immune checkpoint inhibitors

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images

Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.

Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data.

Neuroendocrine differentiation in breast cancer: established facts and unresolved problems

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal

Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research.

Prognostic role of osteopontin expression in malignant pleural mesothelioma

Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.

Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells.

Role of surgical resection in colorectal lung metastases: analysis of 137 patients

Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy era.

Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes

Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.

Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases.

Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy

Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum

Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.

The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers

Therapeutic biomarkers in lung neuroendocrine neoplasia.

Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy.

Tumor/stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis.

What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?

ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization